Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Lagergren

Showing results (361-370 of 378) with videos related to

Pageof 38
Sort By:
British Journal of Sports Medicine|February 2, 2022
Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trialJanine Zylstra, Greg P Whyte, Kerri Beckmann, et al.
Acta Oncologica (Stockholm, Sweden)|February 15, 2021
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection marginsRebecca K Bott, Kerri Beckmann, Janine Zylstra, et al.
Gut|October 30, 2013
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusRebecca C Fitzgerald, Massimiliano di Pietro, Krish Ragunath, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 18, 2015
A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagusJames Y Dai, Jean de Dieu Tapsoba, Matthew F Buas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 14, 2015
Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma riskEunjung Lee, Daniel O Stram, Weronica E Ek, et al.
International Journal of Cancer|September 29, 2015
Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinomaWeronica E Ek, Katarina Lagergren, Michael Cook, et al.
Plos One|September 26, 2015
Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON ConsortiumKatarina Lagergren, Weronica E Ek, David Levine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 23, 2019
Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's EsophagusShao-Hua Xie, Rui Fang, Mingtao Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 20, 2018
Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's EsophagusJing Dong, David M Levine, Matthew F Buas, et al.
Gastroenterology|December 17, 2017
Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic VariantsJing Dong, Matthew F Buas, Puya Gharahkhani, et al.
Pageof 38

Showing results (361-370 of 378) with videos related to

Sort By:
Pageof 38
British Journal of Sports Medicine|February 2, 2022
Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trialJanine Zylstra, Greg P Whyte, Kerri Beckmann, et al.
Acta Oncologica (Stockholm, Sweden)|February 15, 2021
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection marginsRebecca K Bott, Kerri Beckmann, Janine Zylstra, et al.
Gut|October 30, 2013
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusRebecca C Fitzgerald, Massimiliano di Pietro, Krish Ragunath, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 18, 2015
A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagusJames Y Dai, Jean de Dieu Tapsoba, Matthew F Buas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 14, 2015
Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma riskEunjung Lee, Daniel O Stram, Weronica E Ek, et al.
International Journal of Cancer|September 29, 2015
Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinomaWeronica E Ek, Katarina Lagergren, Michael Cook, et al.
Plos One|September 26, 2015
Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON ConsortiumKatarina Lagergren, Weronica E Ek, David Levine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 23, 2019
Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's EsophagusShao-Hua Xie, Rui Fang, Mingtao Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 20, 2018
Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's EsophagusJing Dong, David M Levine, Matthew F Buas, et al.
Gastroenterology|December 17, 2017
Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic VariantsJing Dong, Matthew F Buas, Puya Gharahkhani, et al.
Pageof 38